These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32116839)

  • 1. Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified.
    Spielmans GI; Spence-Sing T; Parry P
    Front Psychiatry; 2020; 11():18. PubMed ID: 32116839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the Pharmacotherapy of Adolescent Depression.
    Masi G
    Curr Pharm Des; 2022; 28(24):1975-1984. PubMed ID: 35619257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning.
    Singh T; Prakash A; Rais T; Kumari N
    Psychiatry (Edgmont); 2009 Oct; 6(10):30-4. PubMed ID: 20011576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
    Gupta S; Gersing KR; Erkanli A; Burt T
    Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ
    Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of adolescent depression in the era of the black box warning.
    Richmond TK; Rosen DS
    Curr Opin Pediatr; 2005 Aug; 17(4):466-72. PubMed ID: 16012257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the FDA Black Box Suicidality Warnings for Antidepressants on Suicide Rates in the USA.
    Plöderl M; Hengartner MP
    Crisis; 2023 Mar; 44(2):128-134. PubMed ID: 34915730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
    Fornaro M; Anastasia A; Valchera A; Carano A; Orsolini L; Vellante F; Rapini G; Olivieri L; Di Natale S; Perna G; Martinotti G; Di Giannantonio M; De Berardis D
    Front Psychiatry; 2019; 10():294. PubMed ID: 31130881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
    Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
    J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends.
    Whitely M; Raven M; Jureidini J
    Front Psychiatry; 2020; 11():478. PubMed ID: 32587531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
    Bushnell GA; Stürmer T; Swanson SA; White A; Azrael D; Pate V; Miller M
    Psychiatr Serv; 2016 Mar; 67(3):302-9. PubMed ID: 26567938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.
    Gibbons RD; Coca Perraillon M; Hur K; Conti RM; Valuck RJ; Brent DA
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):208-14. PubMed ID: 25263479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and youth: healing or harmful?
    Markowitz S; Cuellar A
    Soc Sci Med; 2007 May; 64(10):2138-51. PubMed ID: 17374550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants use in pediatric populations.
    Gören JL
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
    Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicidality Risk of Newer Antiseizure Medications: A Meta-analysis.
    Klein P; Devinsky O; French J; Harden C; Krauss GL; McCarter R; Sperling MR
    JAMA Neurol; 2021 Sep; 78(9):1118-1127. PubMed ID: 34338718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.